MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 25 filers reported holding MOLECULIN BIOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $29,000 | -43.1% | 36,726 | -41.3% | 0.00% | – |
| Q3 2020 | $51,000 | +10.9% | 62,556 | +31.6% | 0.00% | – |
| Q2 2020 | $46,000 | +119.0% | 47,538 | +40.2% | 0.00% | – |
| Q1 2020 | $21,000 | +16.7% | 33,898 | +71.1% | 0.00% | – |
| Q4 2019 | $18,000 | +50.0% | 19,817 | +90.3% | 0.00% | – |
| Q3 2019 | $12,000 | – | 10,412 | +3983.1% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 255 | -69.7% | 0.00% | – |
| Q4 2018 | $1,000 | -83.3% | 841 | -77.7% | 0.00% | – |
| Q3 2018 | $6,000 | +50.0% | 3,778 | +88.9% | 0.00% | – |
| Q4 2017 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | -80.8% | 2,000 | -85.3% | 0.00% | – |
| Q2 2017 | $26,000 | +271.4% | 13,606 | +108.1% | 0.00% | – |
| Q1 2017 | $7,000 | +40.0% | 6,537 | +208.1% | 0.00% | – |
| Q4 2016 | $5,000 | -64.3% | 2,122 | -14.9% | 0.00% | – |
| Q3 2016 | $14,000 | +75.0% | 2,495 | +128.7% | 0.00% | – |
| Q2 2016 | $8,000 | – | 1,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 101,781 | $81,000 | 0.01% |
| Levy Wealth Management Group, LLC | 14,036 | $11,000 | 0.01% |
| WOODMONT INVESTMENT COUNSEL LLC | 12,000 | $10,000 | 0.00% |
| Renaissance Technologies | 948,503 | $756,000 | 0.00% |
| Qube Research & Technologies Ltd | 132,238 | $105,000 | 0.00% |
| Core Wealth Advisors, Inc. | 1,711 | $1,000 | 0.00% |
| UBS Group AG | 36,726 | $29,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Squarepoint Ops LLC | 12,342 | $10,000 | 0.00% |
| TRUE Private Wealth Advisors | 2,500 | $1,000 | 0.00% |